0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Not currently available

Personalized Pathway-Activated Systems Imaging in Oncology - Principal and Instrumentation (Hardcover, 1st ed. 2017) Loot Price: R4,007
Discovery Miles 40 070
You Save: R1,087 (21%)
Personalized Pathway-Activated Systems Imaging in Oncology - Principal and Instrumentation (Hardcover, 1st ed. 2017): Tomio...

Personalized Pathway-Activated Systems Imaging in Oncology - Principal and Instrumentation (Hardcover, 1st ed. 2017)

Tomio Inoue, David Yang, Gang Huang

 (sign in to rate)
List price R5,094 Loot Price R4,007 Discovery Miles 40 070 | Repayment Terms: R376 pm x 12* You Save R1,087 (21%)

Bookmark and Share

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

This comprehensive volume covers radiopharmaceuticals developed for pathway-directed systems in imaging and theranostic applications. We now are at the cutting edge of providing personalized treatment with increased use in oncology of these new radiopharmaceuticals. Trends in high-resolution instrumentation development, quality assurance systems and regulatory compliance for radiopharmaceuticals, clinical evaluation of radiopharmaceuticals, and benefits and pitfalls of the current clinical FDG PET are discussed. Radiopharmaceuticals are used for diagnosis of diseases of the central nervous and cardiovascular systems and for staging, restaging, and treatment planning for cancers. Nuclear biomarkers allow precise measurement of molecular pathways on a whole-body image upon administration of functional radiolabeled agents, and nuclear imaging agents have potential use in patient selection, pharmacokinetic, dosage-finding, and proof-of-concept studies. Nuclear imaging agents and hybrid instrumentation also provide sensitive and specific answers for differential responsiveness in therapeutic outcome. This book serves as a reference for moving the discovery and development of radiopharmaceuticals from the workbench to clinical applications. It thus benefits not only clinicians but also translational research scientists-molecular biologists, chemists, imaging scientists, pharmaceutical developers, physicists, and support staff.

General

Imprint: Springer Verlag, Singapore
Country of origin: Singapore
Release date: March 2017
First published: 2017
Editors: Tomio Inoue • David Yang • Gang Huang
Dimensions: 235 x 155mm (L x W)
Format: Hardcover
Pages: 243
Edition: 1st ed. 2017
ISBN-13: 978-981-10-3348-3
Categories: Books > Medicine > Other branches of medicine > Nuclear medicine
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 981-10-3348-X
Barcode: 9789811033483

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners